Dr.Pravin
☆    

Ahmedabad,
2006-10-05 11:10
(6793 d 14:57 ago)

Posting: # 275
Views: 5,346
 

 Do the Kit (H.Pylori) required BE for Marketing [Design Issues]

I want to know about the Kit required BE Study or not?

Think H.Pylori Kit (Lansoprazole + Clarithromycin + Tinidazole Combination)
so there is any guidline which specify the same.

Dr.Pravin Ahir
Co-Investigator,
Accutest Research Pvt.Lab.(I), Ltd.
Ahmedabad
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2006-10-05 15:44
(6793 d 10:23 ago)

@ Dr.Pravin
Posting: # 277
Views: 4,189
 

 BE for Combination Products

Hello Dr. Pravin!

Since at least gastric resistant lansoprazole is not a candidate for a biowaiver, following rules apply:
  • If the combination is already marketed in the country you are aiming for application, you should demonstrate (in vivo-) BE to the reference kit (first approved product).
  • If the combination is not yet marketed, you must demonstrate BE to a combination of the three single API products.
You should consult the Guidance page for specific informations.

Be prepared for a large sample size in a conventional 2×2 design or a replicate design study, since lansoprazole is a HVD...

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
106 visitors (0 registered, 106 guests [including 5 identified bots]).
Forum time: 02:07 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5